Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

Internal medicine journal·2026

Same author

Longitudinal Changes in Transfusion Practice in Myelodysplastic Syndromes: A Population Data-Linkage Study.

European journal of haematology·2026

Same author

Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study.

Leukemia & lymphoma·2026

Same author

The true cost of red cell transfusion for patients with myelodysplastic syndromes: A time-driven activity-based costing study.

British journal of haematology·2026

Same author

Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Blood·2026

Same author

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Blood advances·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

Large cell lymphoma through a liquid lens.

Jake Shortt^1,2, Stephen Opat^1,2

¹Monash Haematology, Monash Health, Clayton, Victoria, Australia.

British Journal of Haematology

|May 30, 2024

Summary

This summary is machine-generated.

Liquid biopsy using cell-free DNA can profile diffuse large B-cell lymphoma. Achieving a major molecular response indicates a better prognosis for patients with this lymphoma.

Keywords:

EuroClonality NGS DNA Capture diffuse large B cell lymphoma liquid biopsy

More Related Videos

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy

Published on: August 9, 2019

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy

Published on: August 9, 2019

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Area of Science:

Hematology
Oncology
Molecular Diagnostics

Background:

Diffuse large B-cell lymphoma (DLBCL) is a significant hematologic malignancy.
Liquid biopsy offers a non-invasive method for cancer detection and monitoring.
Accurate molecular profiling is crucial for understanding DLBCL heterogeneity and guiding treatment.

Purpose of the Study:

To assess the EuroClonality-NDC assay's utility for profiling DLBCL using cell-free DNA.
To evaluate the prognostic significance of achieving a major molecular response (MMR) in DLBCL patients.
To explore the potential of liquid biopsy in early minimal residual disease assessment for DLBCL.

Main Methods:

Analysis of cell-free DNA (cfDNA) from liquid biopsies.
Application of the EuroClonality-NDC assay for lymphoma profiling.
Correlation of molecular response with patient outcomes.

Main Results:

The EuroClonality-NDC assay is a tractable method for profiling DLBCL via cfDNA.
Attaining a major molecular response is associated with a favorable prognosis.
Liquid biopsy demonstrated potential for early assessment of treatment response.

Conclusions:

Liquid biopsy is a promising tool for molecular characterization of DLBCL.
Major molecular response assessed by liquid biopsy has prognostic implications.
This approach may enhance early detection of minimal residual disease in DLBCL.